These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 15577041

  • 1. [Front line of management of hyperphosphatemia in hemodialysis patients].
    Yumita S.
    Clin Calcium; 2004 May; 14(5):771-7. PubMed ID: 15577041
    [Abstract] [Full Text] [Related]

  • 2. [Evolution in vitamin D treatment after debut of sevelamer hydrochloride in chronic renal failure patients].
    Suzuki M.
    Clin Calcium; 2004 Sep; 14(9):60-3. PubMed ID: 15577112
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J, Piecha G, Kokot F, Wiecek A.
    J Nephrol; 2003 Sep; 16(5):710-5. PubMed ID: 14733418
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients.
    Burke SK, Dillon MA, Hemken DE, Rezabek MS, Balwit JM.
    Adv Ren Replace Ther; 2003 Apr; 10(2):133-45. PubMed ID: 12879374
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
    Ogata H, Koiwa F, Shishido K, Kinugasa E.
    Ther Apher Dial; 2005 Feb; 9(1):11-5. PubMed ID: 15828900
    [Abstract] [Full Text] [Related]

  • 9. The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites.
    Ando R, Naito S, Inagaki Y, Hata T, Ishida Y, Chida Y, Takayama M, Tachibana K, Ohtsuka M, Inoue A.
    Ther Apher Dial; 2005 Feb; 9(1):16-23. PubMed ID: 15828901
    [Abstract] [Full Text] [Related]

  • 10. The role of sevelamer in achieving the kidney disease outcomes quality initiative (K/DOQI) guidelines for hyperphosphatemia.
    Pai AB, Smeeding JE, Brook RA.
    Curr Med Res Opin; 2004 Jul; 20(7):991-9. PubMed ID: 15265243
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical evidence and treatment for optimum concentration of parathyroid hormone, calcium and phosphate in chronic renal failure].
    Hoshino J, Ubara Y, Takaichi K.
    Clin Calcium; 2004 May; 14(5):731-7. PubMed ID: 15577034
    [Abstract] [Full Text] [Related]

  • 13. Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysis.
    Huybrechts KF, Caro JJ, Wilson DA, O'Brien JA.
    Value Health; 2005 May; 8(5):549-61. PubMed ID: 16176493
    [Abstract] [Full Text] [Related]

  • 14. [Relationship between sevelamer HCl and vascular calcification].
    Uemura K, Kakuta T, Saito A.
    Clin Calcium; 2007 Mar; 17(3):392-8. PubMed ID: 17339744
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
    Nolan CR, Qunibi WY.
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):373-9. PubMed ID: 12815333
    [Abstract] [Full Text] [Related]

  • 17. [Critical appraisal of sevelamer for the treatment of hyperphosphatemia in patients with chronic renal failure].
    Sesso R, Ferraz MB.
    Rev Assoc Med Bras (1992); 2003 Jul; 49(1):103-8. PubMed ID: 12724821
    [Abstract] [Full Text] [Related]

  • 18. Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients.
    Gallieni M, Cozzolino M, Carpani P, Zoni U, Brancaccio D.
    J Nephrol; 2001 Jul; 14(3):176-83. PubMed ID: 11439741
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of coronary artery calcification in ESRD patients].
    Yokoyama K.
    Clin Calcium; 2004 Jun; 14(6):109-15. PubMed ID: 15577064
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.